Literature DB >> 17277348

Right ventricular hypertrophy and diastolic dysfunction in arterial switch patients without pulmonary artery stenosis.

H B Grotenhuis1, L J M Kroft, S G C van Elderen, J J M Westenberg, J Doornbos, M G Hazekamp, H W Vliegen, J Ottenkamp, A de Roos.   

Abstract

OBJECTIVE: To assess pulmonary flow dynamics and right ventricular (RV) function in patients without significant anatomical narrowing of the pulmonary arteries late after the arterial switch operation (ASO) by using magnetic resonance imaging (MRI).
METHODS: 17 patients (mean (SD), 16.5 (3.6) years after ASO) and 17 matched healthy subjects were included. MRI was used to assess flow across the pulmonary trunk, RV systolic and diastolic function, and RV mass.
RESULTS: Increased peak flow velocity (>1.5 m/s) was found across the pulmonary trunk in 14 of 17 patients. Increased RV mass was found in ASO patients: 14.9 (3.4) vs 10.0 (2.6) g/m2 in normal subjects (p<0.01). Delayed RV relaxation was found after ASO: mean tricuspid valve E/A peak flow velocity ratio = 1.60 (0.96) vs 1.92 (0.61) in normal subjects (p = 0.03), and E-deceleration gradients = -1.69 (0.73) vs -2.66 (0.96) (p<0.01). After ASO, RV mass correlated with pulmonary trunk peak flow velocity (r = 0.49, p<0.01) and tricuspid valve E-deceleration gradients (r = 0.35, p = 0.04). RV systolic function was well preserved in patients (ejection fraction = 53 (7)% vs 52 (8)% in normal subjects, p = 0.72).
CONCLUSIONS: Increased peak flow velocity in the pulmonary trunk was often observed late after ASO, even in the absence of significant pulmonary artery stenosis. Haemodynamic consequences were RV hypertrophy and RV relaxation abnormalities as early markers of disease, while systolic RV function was well preserved.

Entities:  

Mesh:

Year:  2007        PMID: 17277348      PMCID: PMC2095768          DOI: 10.1136/hrt.2006.109199

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  23 in total

1.  Arterial switch procedure for D-transposition of the great arteries: quantitative midterm evaluation of hemodynamic changes with cine MR imaging and phase-shift velocity mapping-initial experience.

Authors:  M Gutberlet; T Boeckel; N Hosten; M Vogel; T Kühne; H Oellinger; T Ehrenstein; S Venz; R Hetzer; G Bein; R Felix
Journal:  Radiology       Date:  2000-02       Impact factor: 11.105

Review 2.  Quantification in cardiac MRI.

Authors:  R J van der Geest; J H Reiber
Journal:  J Magn Reson Imaging       Date:  1999-11       Impact factor: 4.813

3.  Comparison of pulmonary arterial flow phenomena in spiral and Lecompte models by computational fluid dynamics.

Authors:  T Tang; I S Chiu; H C Chen; K Y Cheng; S J Chen
Journal:  J Thorac Cardiovasc Surg       Date:  2001-09       Impact factor: 5.209

4.  Sensitivity encoded cardiac MRI.

Authors:  K P Pruessmann; M Weiger; P Boesiger
Journal:  J Cardiovasc Magn Reson       Date:  2001       Impact factor: 5.364

5.  Fixed region of nondistensibility after coarctation repair: in vitro validation of its influence on Doppler peak velocities.

Authors:  H Verhaaren; S De Mey; I Coomans; P Segers; D De Wolf; D Matthys; P Verdonck
Journal:  J Am Soc Echocardiogr       Date:  2001-06       Impact factor: 5.251

6.  The influence of diastolic and systolic function on exercise performance in heart failure due to dilated cardiomyopathy or ischemic heart disease.

Authors:  M Pepi; P Agostoni; G Marenzi; E Dorai; M Guazzi; G Lauri; A Maltagliati; M Guazzi
Journal:  Eur J Heart Fail       Date:  1999-06       Impact factor: 15.534

Review 7.  Assessment of diastolic function by cardiovascular magnetic resonance.

Authors:  Bernard P Paelinck; Hildo J Lamb; Jeroen J Bax; Ernst E Van der Wall; Albert de Roos
Journal:  Am Heart J       Date:  2002-08       Impact factor: 4.749

8.  Time course of diastolic and systolic function improvement after pulmonary valve replacement in adult patients with tetralogy of Fallot.

Authors:  Alexander van Straten; Hubert W Vliegen; Hildo J Lamb; Stijntje D Roes; Ernst E van der Wall; Mark G Hazekamp; Albert de Roos
Journal:  J Am Coll Cardiol       Date:  2005-09-23       Impact factor: 24.094

9.  Treatment of pulmonary artery stenosis after arterial switch operation: stent implantation vs. balloon angioplasty.

Authors:  R Formigari; G Santoro; P Guccione; A Giamberti; L Pasquini; M Grigioni; L Ballerini
Journal:  Catheter Cardiovasc Interv       Date:  2000-06       Impact factor: 2.692

Review 10.  Diastolic heart failure.

Authors:  L Mandinov; F R Eberli; C Seiler; O M Hess
Journal:  Cardiovasc Res       Date:  2000-03       Impact factor: 10.787

View more
  11 in total

1.  Postoperative pulmonary and aortic 3D haemodynamics in patients after repair of transposition of the great arteries.

Authors:  Julia Geiger; Daniel Hirtler; Jonas Bürk; Brigitte Stiller; Raoul Arnold; Bernd Jung; Mathias Langer; Michael Markl
Journal:  Eur Radiol       Date:  2013-09-01       Impact factor: 5.315

2.  Follow-up outcomes 10 years after arterial switch operation for transposition of the great arteries: comparison of cardiological health status and health-related quality of life to those of the a normal reference population.

Authors:  Wilfred B de Koning; Magdalena van Osch-Gevers; A Derk Jan Ten Harkel; Ron T van Domburg; Alma W Spijkerboer; Elisabeth M W J Utens; Ad J J C Bogers; Willem A Helbing
Journal:  Eur J Pediatr       Date:  2007-11-07       Impact factor: 3.183

3.  Watching the right ventricle in treated congenital heart disease.

Authors:  Thomas L Gentles
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

Review 4.  Ventricular performance after surgery for a congenital heart defect as assessed using advanced echocardiography: from doppler flow to 3D echocardiography and speckle-tracking strain imaging.

Authors:  Liselotte M Klitsie; Arno A W Roest; Nico A Blom; Arend D J ten Harkel
Journal:  Pediatr Cardiol       Date:  2014-01       Impact factor: 1.655

5.  Is the Lecompte technique the last word on transposition of the great arteries repair for all patients? A magnetic resonance imaging study including a spiral technique two decades postoperatively.

Authors:  Carsten Rickers; Arash Kheradvar; Hans-Hinrich Sievers; Ahmad Falahatpisheh; Philip Wegner; Dominik Gabbert; Michael Jerosch-Herold; Chris Hart; Inga Voges; Léon M Putman; Ines Kristo; Gunther Fischer; Jens Scheewe; Hans-Heiner Kramer
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-02-25

6.  Exercise Performance in Patients with D-Loop Transposition of the Great Arteries After Arterial Switch Operation: Long-Term Outcomes and Longitudinal Assessment.

Authors:  Joseph D Kuebler; Ming-Hui Chen; Mark E Alexander; Jonathan Rhodes
Journal:  Pediatr Cardiol       Date:  2015-10-06       Impact factor: 1.655

7.  Assessment of the precision and reproducibility of ventricular volume, function, and mass measurements with ferumoxytol-enhanced 4D flow MRI.

Authors:  Kate Hanneman; Aya Kino; Joseph Y Cheng; Marcus T Alley; Shreyas S Vasanawala
Journal:  J Magn Reson Imaging       Date:  2016-02-12       Impact factor: 4.813

8.  [Preoperative and postoperative imaging in patients with transposition of the great arteries].

Authors:  M Gutberlet; J Hoffmann; E Künzel; A Fleischer; S Sarikouch; P Beerbaum; L Lehmkuhl; C Andres; P Lurz; M Kostelka; H Abdul-Khaliq; I Dähnert; M Grothoff
Journal:  Radiologe       Date:  2011-01       Impact factor: 0.635

9.  Evaluation of knowledge-based reconstruction for magnetic resonance volumetry of the right ventricle after arterial switch operation for dextro-transposition of the great arteries.

Authors:  Emile C A Nyns; Andreea Dragulescu; Shi-Joon Yoo; Lars Grosse-Wortmann
Journal:  Int J Cardiovasc Imaging       Date:  2016-06-02       Impact factor: 2.357

10.  Right ventricular afterload in repaired D-TGA is associated with inefficient flow patterns, rather than stenosis alone.

Authors:  Marc Delaney; Vincent Cleveland; Paige Mass; Francesco Capuano; Jason G Mandell; Yue-Hin Loke; Laura Olivieri
Journal:  Int J Cardiovasc Imaging       Date:  2021-11-02       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.